In today's fast-paced world, respiratory health is often neglected, especially for those suffering from chronic conditions ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Popular but pricey weight-loss drugs Ozempic and Wegovy are among the 15 medications whose prices will be subject to direct negotiations between Medicare and drug makers.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Patients with acute COPD exacerbations are seen frequently in ... for intubation when NPPV was used instead of standard therapy. There was also a decrease in overall mortality and decreased ...

COPD is a chronic lung disease that makes it increasingly difficult for sufferers to breathe. There’s no cure for the condition, which grows steadily worse over time. Previous research has shown ...

“I've got pins on my leg and I’ve got COPD, so having to go up those stairs is a problem. “I was at a fracture unit the other morning, my daughter took us in to do my shopping and I had to carry the ...